Indication
Cryptococcal Meningitis
5 clinical trials
6 products
Product
MAT2203Product
Amphotericin BClinical trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis TrialStatus: Completed, Estimated PCD: 2022-11-14
Clinical trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3Status: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Multi-center, Prospective, Randomized Trial of Amphotericin B in the Initial Antifungal Therapy for Non-HIV Cryptococcal Meningitis PatientsStatus: , Estimated PCD: 2025-08-31
Clinical trial
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal MeningitisStatus: Recruiting, Estimated PCD: 2024-09-01
Product
AMBITIONProduct
FlucytosineClinical trial
Evaluation of CrAg Screening With Enhanced Antifungal Therapy for Asymptomatic CrAg+ PersonsStatus: Recruiting, Estimated PCD: 2027-10-01
Product
Fluconazole